Skip to main content
Premium Trial:

Request an Annual Quote

Hunkapiller Retires from Applied Biosystems

NEW YORK, Aug. 23 (GenomeWeb News) - Applera said today that Michael Hunkapiller, senior vice president and president of the company's Applied Biosystems group, has retired.

 

The company also announced that Hunkapiller has been replaced by Catherine Burzik, former executive vice president and COO.

 

"The company is indebted to Mike for his many pioneering contributions over the past two decades," Tony White, CEO of Applera, said in a statement. "Cathy Burzik joined us in September 2003 from Johnson & Johnson where she was president of their Ortho-Clinical Diagnostics business. Cathy has extensive operating experience in running complex global businesses, and we look forward to her leadership and contributions to Applied Biosystems going forward," he added.

 

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.